½Å°æÁúȯ(Neurodegenerative Disease) Ä«Å×°í¸®¿¡¼´Â ½Å°æº¯¼º Áúȯ(´Ù¹ß¼º°æÈÁõ(MS), Ä¡¸Å, ¾ËÃ÷ÇÏÀ̸Ӻ´, °£Áú µî)À» Á¶»ç ´ë»óÀ¸·Î ÇÑ º¸°í¼¸¦ ¼Ò°³ÇØ µå¸®°í ÀÖ½À´Ï´Ù. ÁßÃ߽Űæ°è ¾à¹° ÆÄÀÌÇÁ¶óÀÎ ¹× ¿¬±¸°³¹ß °ü·Ã °úÁ¦, ½ÃÀåÀÇ °¡´É¼º µî¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇÑ º¸°í¼µµ Çѵ¥ ¸ð¾Ò½À´Ï´Ù.
![]() |
¼¼°èÀÇ ÇÁ·¹°¡¹ß¸° ½ÃÀå
Pregabalin
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ½Å°æº´Áõ¼º ÅëÁõ ½ÃÀå
Neuropathic Pain
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ½Å°æº¯¼º Ä¡·áÁ¦ ½ÃÀå
Neurodegenerative Drugs
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ºÎ½Å¹éÁúÀÌ¿µ¾çÁõ ½ÃÀå : Áö¿ª ¹× ±¹°¡º° ºÐ¼®°ú ¿¹Ãø(2025-2035³â)
Adrenoleukodystrophy Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 4,900
![]() |
![]() |
¾ËÃ÷ÇÏÀ̸Ӻ´ ½ÃÀå : Ä¡·á À¯Çüº°, Áõ»ó ÀûÀÀº°, ÁÖ¿ä Áö¿ªº°
Alzheimer's Disease Market Distribution by Type of Treatment, Symptomatic Indications, and Key Geographical Regions
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 4,799
![]() |
![]() |
¼¼°èÀÇ ³µ¶Áõ Ä¡·á ½ÃÀå
Dyslexia Treatment
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ·¹º¸µµÆÄ ½ÃÀå
Levodopa
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ÇнÀÀå¾Ö Ä¡·á ½ÃÀå
Learning Disabilities Treatment
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ¾ËÃ÷ÇÏÀ̸Ӻ´ Ä¡·áÁ¦ ½ÃÀå(2025-2029³â)
Global Alzheimers Disease Therapeutics Market 2025-2029
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 2,500
![]() |
![]() |
¼¼°èÀÇ ½Ã½Å°æÃ´¼ö¿° ½ºÆåÆ®·³ Àå¾Ö ½ÃÀå º¸°í¼(2025³â)
Neuromyelitis Optica Spectrum Disorder Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ ½Å°æÆ÷ÂøÁõÈıº ½ÃÀå º¸°í¼(2025³â)
Nerve Entrapment Syndrome Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ ÇåÆÃÅϺ´ ½ÃÀå º¸°í¼(2025³â)
Huntington's Disease Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
Äݸ°¿¡½ºÅ×¶ó¾ÆÁ¦ ÀúÇØÁ¦ ÀçȰ¼ºÈÁ¦ ½ÃÀå º¸°í¼ : µ¿Çâ, ¿¹Ãø, °æÀï ºÐ¼®(-2031³â)
Cholinesterase Inhibitor Reactivator Market Report: Trends, Forecast and Competitive Analysis to 2031
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 3,850
![]() |
![]() |
±æ·© ¹Ù·¹ ÁõÈıº Ä¡·áÁ¦ ½ÃÀå : Ä¡·á À¯Çü, ¾àÁ¦ Ŭ·¡½ºº°, À¯Åë ä³Îº°, Áö¿ªº°(2026-2032³â)
Guillain Barre Syndrome Drugs Market by Treatment Type, Drug Class, Distribution Channel, & Region For 2026-2032
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 3,950
![]() |
![]() |
¼¼°èÀÇ ÈíÀÔÇü ÁßÃ߽Űæ°è Ä¡·áÁ¦ ½ÃÀå : Á¦Ç°, ½ÃÀå, Àü·«, ¿¹Ãø, Ç¥Àû
Inhaled CNS Therapeutics, Products, Markets, Therapeutics, Strategies & Forecasts
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 3,850
![]() |
![]() |
´Ù¹ß¼º °æÈÁõ - °æÀï ±¸µµ(2025³â)
Multiple Sclerosis - Competitive landscape, 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 3,000
![]() |
![]() |
¼¼°èÀÇ »ïÂ÷ ½Å°æÅë Ä¡·á ½ÃÀå º¸°í¼(2025³â)
Trigeminal Neuralgia Treatment Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ ¸»ÃÊ ½Å°æ¿° Ä¡·á ½ÃÀå º¸°í¼(2025³â)
Peripheral Neuritis Treatment Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ ÆÄŲ½¼º´ ½ÃÀå º¸°í¼(2025³â)
Parkinson's Disease Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ ºÎ½Å°æÀýÁ¾ ½ÃÀå º¸°í¼(2025³â)
Paraganglioma Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ ½Å°æ ¼¶À¯Á¾Áõ 1Çü ½ÃÀå º¸°í¼(2025³â)
Neurofibromatosis Type 1 Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ ±æ·©-¹Ù·¹ ÁõÈıº ½ÃÀå º¸°í¼(2025³â)
Guillain-Barre Syndrome Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ ³úô¼ö¿° ½ÃÀå º¸°í¼(2025³â)
Encephalomyelitis Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ ÀÚÀ²½Å°æ½ÇÁ¶Áõ ½ÃÀå º¸°í¼(2025³â)
Dysautonomia (Autonomic Dysfunction) Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 4,490
![]() |
![]() |
¼¼°èÀÇ µå¶óº£ ÁõÈıº ½ÃÀå º¸°í¼(2025³â)
Dravet Syndrome Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý
US $ 4,490
![]() |